Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward.
about
Antimicrobial resistance in Acinetobacter baumannii: From bench to bedsideBiology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsAntimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials.Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamasePCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan.Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.Acinetobacter baumannii: emergence of a successful pathogenPhenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilitiesVEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.Global challenge of multidrug-resistant Acinetobacter baumanniiPhenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, CaliforniaNovel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.Therapeutic options for Acinetobacter baumannii infections.Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil.Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.Treatment options for multidrug-resistant nonfermenters.Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter baumannii.Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.Genetic basis of antibiotic resistance in pathogenic Acinetobacter species.Acinetobacter: a potential reservoir and dispenser for β-lactamases.Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria.Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date.Genetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti.Acinetobacter baumannii quorum-sensing signalling molecule induces the expression of drug-resistance genes.PER-8, a Novel Extended-Spectrum β-Lactamase PER Variant, from an Acinetobacter baumannii Clinical Isolate in Nepal.Co-production of ESBL and AmpC β-Lactamases in Clinical Isolates of A. baumannii and A. lwoffii in a Tertiary Care Hospital From Northern India.Diversity of clavulanic acid-inhibited extended-spectrum β-lactamases in Aeromonas spp. from the Seine River, Paris, France.Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confirmation tests.PER-7, an extended-spectrum beta-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumanniiSpread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.Genotypic characteristics of multidrug-resistant Pseudomonas aeruginosa from hospital wastewater treatment plant in Rio de Janeiro, Brazil.Phenotypic and molecular characterization of 5 novel CTX-M enzymes carried by Klebsiella pneumoniae and Escherichia coli.CTX-M-1 β-lactamase expression in Escherichia coli is dependent on cefotaxime concentration, growth phase and gene location.Dissemination of ceftazidime-resistant Acinetobacter baumannii clonal complex 92 in Korea
P2860
Q27024893-62C24564-3A36-4EF6-98A1-F05C1994AD55Q30235064-10504A71-DC59-44AA-8455-A43CC5760545Q33593516-90FC2338-C312-49DE-87C7-C11CE9B2A85BQ33857639-CEA96AB3-54D6-47CF-9D55-D87571E22172Q34351969-2CAF5614-33D3-4C12-9E10-730D4934C7DCQ34555131-C6C7F284-1608-4C54-9269-B310AF4B29EEQ34795807-014A44E1-8779-43DA-B508-1A68782A6921Q35066715-AE100C63-5035-4FF1-B1A7-A91A7BA3CE87Q35793194-D2E602BC-39B8-41C1-892B-0AEA5803D51AQ35905605-CCEF5AC3-3202-49DE-8A49-86FBF5A79CD7Q36095081-09F84AD4-ADCA-4D66-8301-CFA15C558119Q36845404-ED54DF13-EEC9-4D2B-81F9-5D3AE4E571FDQ37032894-05FBCE6E-43F0-4747-8307-4F2B7BD0390CQ37099006-5127641A-C335-4CA1-9F65-21661FB753B4Q37333114-9663D8C0-5284-450C-8C21-BB68E1867CD9Q37656243-A336DC2E-A5CA-40FA-BC5F-34C561FC4CD1Q37700555-68D8F73B-0D0A-47D5-A1C1-62031200CB99Q37838117-79E63EFE-5C28-4F37-ADD7-E632FA474357Q37869910-5F2BDA26-E1D1-4DDA-A7B9-6B2D50204D9DQ37944605-7E432EC0-0A86-427B-9E0D-92E3079FF21DQ37946953-EFB3BD0B-EB04-410C-B0BA-713D61F5789BQ38018625-9BBC7EDA-1514-4347-B873-23A28021E359Q38113258-A84C23D4-1DB4-4A19-BCCD-470B15106CB2Q38232199-454F6F0C-2FD0-4D3F-AD05-E35B9F0A6C40Q39660188-B5B2EABB-F2E6-4709-A1C0-0A0F802BED84Q40219351-48006585-6F42-4FE4-A4C5-3F96FAEA0310Q40392488-E077796A-20C9-4F18-95C5-0FCE8C603513Q40931929-55DF0AE1-04CA-4F88-941B-99D0B812C1F9Q41837614-BE704668-F4C5-4900-BA96-97B3F1530EC1Q41878926-1DB1F942-3DB4-4778-A81F-F7B68CE16C7CQ41901517-23C0DEB1-726A-45D3-A2D0-FE19D5622D42Q41985167-AAF16D4E-8E28-46D5-ABC5-BA5D437BAB98Q43330447-D815C50D-405F-4F2E-9BB7-2D3EBA94B2D2Q46794517-3E55AB96-49A6-4A94-A876-2A82A3DAD03DQ54192989-FEFFB630-A233-436A-8B88-87E3A227BB43Q57225241-6891B7A6-463C-44D3-96E1-428EF69B4296
P2860
Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nosocomial transmission of CTX ...... mannii in a neurosurgery ward.
@en
Nosocomial transmission of CTX ...... mannii in a neurosurgery ward.
@nl
type
label
Nosocomial transmission of CTX ...... mannii in a neurosurgery ward.
@en
Nosocomial transmission of CTX ...... mannii in a neurosurgery ward.
@nl
prefLabel
Nosocomial transmission of CTX ...... mannii in a neurosurgery ward.
@en
Nosocomial transmission of CTX ...... mannii in a neurosurgery ward.
@nl
P2093
P2860
P1476
Nosocomial transmission of CTX ...... mannii in a neurosurgery ward.
@en
P2093
Christophe Cordevant
Naohiro Shibata
Noriyuki Nagano
Yoshichika Arakawa
Yukiko Nagano
P2860
P304
P356
10.1128/JCM.42.9.3978-3984.2004
P407
P577
2004-09-01T00:00:00Z